Addictions
BC Addictions Expert Questions Ties Between Safer Supply Advocates and For-Profit Companies

By Liam Hunt
Canada’s safer supply programs are “selling people down the river,” says a leading medical expert in British Columbia. Dr. Julian Somers, director of the Centre for Applied Research in Mental Health and Addiction at Simon Fraser University, says that despite the thin evidence in support of these experimental programs, the BC government has aggressively expanded them—and retaliated against dissenting researchers.
Somers also, controversially, raises questions about doctors and former health officials who appear to have gravitated toward businesses involved in these programs. He notes that these connections warrant closer scrutiny to ensure public policies remain free from undue industry influence.
Safer supply programs claim to reduce overdoses and deaths by distributing free addictive drugs—typically 8-milligram tablets of hydromorphone, an opioid as potent as heroin—to dissuade addicts from accessing riskier street substances. Yet, a growing number of doctors say these programs are deeply misguided—and widely defrauded.
Ultimately, Somers argues, safer supply is exacerbating the country’s addiction crisis.
Somers opposed safer supply at its inception and openly criticized its nationwide expansion in 2020. He believes these programs perpetuate drug use and societal disconnection and fail to encourage users to make the mental and social changes needed to beat addiction. Worse yet, the safer supply movement seems rife with double standards that devalue the lives of poorer drug users. While working professionals are provided generous supports that prioritize recovery, disadvantaged Canadians are given “ineffective yet profitable” interventions, such as safer supply, that “convey no expectation that stopping substance use or overcoming addiction is a desirable or important goal.”
To better understand addiction, Somers created the Inter-Ministry Evaluation Database (IMED) in 2004, which, for the first time in BC’s history, connected disparate information—i.e. hospitalizations, incarceration rates—about vulnerable populations.
Throughout its existence, health experts used IMED’s data to create dozens of research projects and papers. It allowed Somers to conduct a multi-million-dollar randomized control trial (the “Vancouver at Home” study) that showed that scattering vulnerable people into regular apartments throughout the city, rather than warehousing them in a few buildings, leads to better outcomes at no additional cost.
In early 2021, Somers presented recommendations drawn from his analysis of the IMED to several leading officials in the B.C. government. He says that these officials gave a frosty reception to his ideas, which prioritized employment, rehabilitation, and social integration over easy access to drugs. Shortly afterwards, the government ordered him to immediately and permanently delete the IMED’s ministerial data.
Somers describes the order as a “devastating act of retaliation” and says that losing access to the IMED effectively ended his career as a researcher. “My lab can no longer do the research we were doing,” he noted, adding that public funding now goes exclusively toward projects sympathetic to safer supply. The B.C. government has since denied that its order was politically motivated.
In early 2022, the government of Alberta commissioned a team of researchers, led by Somers, to investigate the evidence base behind safer supply. They found that there was no empirical proof that the experiment works, and that harm reduction researchers often advocated for safer supply within their studies even if their data did not support such recommendations.
Somers says that, after these findings were published, his team was subjected to a smear campaign that was partially organized by the British Columbia Centre on Substance Use (BCCSU), a powerful pro-safer supply research organization with close ties to the B.C. government. The BCCSU has been instrumental in the expansion of safer supply and has produced studies and protocols in support of it, sometimes at the behest of the provincial government.
Somers is also concerned about the connections between some of safer supply’s key proponents and for-profit drug companies.
He notes that the BCCSU’s founding executive director, Dr. Evan Wood, became Chief Medical Officer at Numinus Wellness, a publicly traded psychedelic company, in 2020. Similarly, Dr. Perry Kendall, who also served as a BCCSU executive director, went on to found Fair Price Pharma, a now-defunct for-profit company that specializes in providing pharmaceutical heroin to high-risk drug users, the following year.
While these connections are not necessarily unethical, they do raise important questions about whether there is enough industry regulation to minimize potential conflicts of interest, whether they be real or perceived.
The BCCSU was also recently criticized in an editorial by Canadian Affairs, which noted that the organization had received funding from companies such as Shoppers Drug Mart and Tilray (a cannabis company). The editorial argued that influential addiction research organizations should not receive drug industry funding and reported that Alberta founded its own counterpart to the BCCSU in August, known as the Canadian Centre of Recovery Excellence, which is legally prohibited from accepting such sponsorships.
Already, private interests are betting on the likely expansion of safer supply programs. For instance, Safe Supply Streaming Co., a publicly traded venture capital firm, has advertised to potential investors that B.C.’s safer supply system could create a multi-billion-dollar annual market.
Somers believes that Canada needs more transparency regarding how for-profit companies may be directly or indirectly influencing policy makers: “We need to know exactly, to the dollar, how much of [harm reduction researchers’] operating budget is flowing from industry sources.”
Editor’s note: This story is published in syndication with Break The Needle and Western Standard.
The Bureau is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Dr. Julian M. Somers is director of the Centre for Applied Research in Mental Health and Addiction at Simon Fraser University. He was Director of the UBC Psychology Clinic, and past president of the BC Psychological Association. Liam Hunt is a contributing author to the Centre For Responsible Drug Policy in partnership with the Macdonald-Laurier Institute.
Addictions
Saskatchewan launches small fleet of wellness buses to expand addictions care

By Alexandra Keeler
Across Canada, mobile health models are increasingly being used to offer care to rural and underserved communities
Saskatchewan has launched a small fleet of mobile wellness buses to improve access to primary health care, mental health and addiction services in the province.
The first bus began operating in Regina on Feb. 12. Another followed in Prince Albert on March 21. Saskatoon’s bus was unveiled publicly on April 9. All three are former coach buses that have been retrofitted to provide health care to communities facing barriers to access.
“Mobile health units are proven to improve outcomes for people facing barriers to healthcare,” Kayla DeMong, the executive director of addiction treatment centre Prairie Harm Reduction, told Canadian Affairs in an email.
“We fully support this innovative approach and are excited to work alongside the health bus teams to ensure the people we support receive the care they need, when and where they need it.”
Wellness buses
Like all provinces, Saskatchewan has been grappling with the opioid crisis.
In 2023, an estimated 457 individuals died from overdoses in the province. In 2024, that number fell to 346. But the province continues to struggle with fatal and non-fatal overdoses.
In late February, Saskatoon firefighters responded to more than 25 overdoses in a single 24-hour period. Just over a week later, they responded to 37 overdoses within another 24-hour window.
Saskatchewan’s wellness buses are part of the province’s plan to address these problems. In April 2025, the province announced $2.4 million to purchase and retrofit three coach buses, plus $1.5 million in annual operating funds.
The buses operate on fixed schedules at designated locations around each city. Each bus is staffed with a nurse practitioner, nurse and assessor coordinator who offer services such as overdose reversal kits, addiction medicine and mental health referrals.
“By bringing services directly to where people are, the health buses foster safer, more welcoming spaces and help build trusting relationships between community members and care providers,” said DeMong, executive director of Prairie Harm Reduction.
Saskatoon-based Prairie Harm Reduction is one of the local organizations that partners with the buses to provide additional support services. Prairie Harm Reduction provides a range of family, youth and community supports, and also houses the province’s only fixed supervised consumption site.
The mobile model
Saskatchewan is not the only province using wellness buses. Across Canada, mobile health models are increasingly being used to expand access to care in rural and underserved communities.
In Kingston, Ont., the Street Health Centre operates a retrofitted RV called PORCH (Portable Outreach Care Hub) that serves individuals struggling with homelessness and addiction.
“Our outreach services are extremely popular with our clients and community partners,” Donna Glasspoole, manager at Street Health Centre, said in an emailed statement.
“PORCH hits the road two to three days/week and offers a variety of services, which are dependent on the health care providers and community partners aboard.”
Street Health Centre also has a shuttle service that picks up clients in shelters and brings them to medical clinics or addiction medicine clinics.
The PORCH vehicles are not supported by provincial funding, but instead rely on support from the United Way and other grants. Glasspoole says the centre’s permanent location — which does receive government funding — is more cost-effective to operate.
“The vehicles are expensive to operate and our RV is not great in winter months and requires indoor parking,” she said.

Politically palatable
Many mobile health models currently do not provide controversial services such as supervised drug consumption.
The Saskatchewan Health Authority told Canadian Affairs the province’s new wellness buses will not offer supervised consumption services or safer supply, where drug users are given prescribed opioids as an alternative to toxic street drugs.
“There are no plans to provide supervised consumption services from the wellness buses,” Saskatchewan Health Authority spokesperson Courtney Markewich told Canadian Affairs in a phone call.
This limited scope may make mobile services more politically palatable in provinces that have resisted harm reduction measures.
In Ontario, some harm reduction programs have shifted to mobile models following Premier Doug Ford’s decision to suspend supervised consumption services located within 200 metres of schools and daycares.
In April, Toronto Public Health ended operations at its Victoria Street fixed consumption site, replacing it with street outreach and mobile vans.
The Ontario government’s decision to close the sites is part of a broader pivot away from harm reduction. The province is investing $378 million to transition suspended sites into 19 new “HART Hubs” that offer primary care, mental health, addictions treatment and other supports.
Glasspoole says that what matters most is not whether services are provided at fixed or mobile locations, but how care is delivered.
Models that “reduce barriers to care, [are] non-judgemental, and [are staffed by] trauma-informed providers” are what lead more people toward treatment and recovery, she said in her email.
In Saskatchewan, DeMong hopes the province’s new wellness buses help address persistent service gaps and build trust with underserved communities.
“This initiative is a vital step toward filling long-standing gaps in the continuum of care by providing low-barrier, community-based access to health-care services,” she said.
This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.
Subscribe to Break The Needle
Addictions
Man jailed for trafficking diverted safer supply drugs, sparking fresh debate over B.C. drug policies

Nanaimo drug trafficker’s case is further evidence of safer supply diversion. But some sources say even diverted drugs reduce harm
In early May, 68-year-old Ronald Schilling of Nanaimo, B.C., was sentenced to three years in prison for trafficking street drugs such as fentanyl and meth — as well as government-supplied opioids.
When authorities had arrested Schilling two years earlier, they had found him in possession of more than 80 government-supplied opioid pill bottles labeled with other patients’ names.
Those pills had been dispensed to patients under B.C.’s “prescribed alternatives” program, more commonly known as safer supply. The program aims to reduce overdose deaths by dispensing pharmaceutical opioids to drug users as an alternative to toxic street drugs.
In Schilling, patients of this program had found a drug dealer who was willing to give them harder drugs — such as fentanyl — in exchange for their prescription opioids. Schilling would in turn sell their prescription opioids to others.
“Mr. Schilling preyed upon people who were taking the safe supply drug,” Provincial Court Judge Karen Whonnock said during the sentencing hearing.
Schilling’s case is further evidence that safer supply opioids are making their way to the streets — and having unintended negative consequences. However, some sources say even diverted pills reduce harm if they flood the market with safer drugs.
‘Upside Down’
Schilling, a former charity worker, developed a cocaine addiction after the sudden death of his partner. He ultimately turned to drug trafficking to fund his addiction, according to his lawyer.
In court, the prosecution described Schilling as operating a mid-level drug trafficking scheme that exploited B.C.’s safer supply program.
Schilling coordinated with multiple dealers to source both illicit and prescription drugs, and had at least three individuals working under him. His text messages showed he would arrange to meet clients near Nanaimo’s Outreach Pharmacy to trade potent street drugs for the prescribed medications they had just received.
He operated under the name “Upside Down Inc.” — “down” being a street reference to fentanyl — and had business cards to match. To reassure users that the street drugs were safe, he would have them tested at a local overdose prevention site.
‘Predatory behaviour’
While Schilling’s case is unusual, it adds to the growing body of evidence that provincial safer supply programs are not always being used as intended.
In one example, a B.C. government report released in February revealed that more than 60 pharmacies were involved in a kick-back scheme, offering patients cash or rewards to fill safer supply prescriptions they did not need. Some of those drugs were then sold on the black market.
Collen Middleton, a co-founder of the Nanaimo Area Public Safety Association, refers to safer supply drugs as the “perfect consumer product.”
“They are a product that produces its own demand, because it’s addictive,” said Middleton, whose neighbourhood association is a vocal critic of safer supply.
One of Middleton’s concerns is that safer supply drugs are presented as safe, despite being addictive themselves. He says this makes them an effective gateway to more dangerous street drugs like fentanyl.
“Those drugs are being marketed as safe to kids … [so] you’re bringing more people into using addictive drugs, more abuse, more predatory behaviour toward a vulnerable segment of the population,” he said.
The B.C. Ministry of Health told Canadian Affairs in an emailed statement that it takes the “diversion of prescription medications … very seriously.”
“The unauthorized distribution is illegal and puts the public at risk,” it said.
In response to the B.C. pharmacy scandal, the province tightened its protocols for dispensing prescription opioids. All new and most existing patients must take prescription opioids under the supervision of health-care professionals, a protocol known as witnessed dosing. In rare cases, existing clients may continue to take their doses offsite if the prescriber views the risk of diversion as low.
Mixed evidence
In its statement to Canadian Affairs, B.C.’s health ministry also said its safer supply program “plays an important role in reducing substance use-related harms” and can lower overdose risk by as much as 91 per cent.
This figure comes from a 2024 B.C. study published in the British Medical Journal. That study found individuals prescribed pharmaceutical opioids early in the pandemic were 91 per cent less likely to die from any cause in the week after receiving at least four days of safer supply opioids, compared to a control group.
The study only tracked outcomes during the week following prescription fills. It did not verify whether individuals took the opioids as prescribed.
A study published in April in The Lancet Public Health shows B.C.’s safer supply programs are linked to improved short-term health outcomes, including fewer overdoses and hospital visits.
However, a population-level study in JAMA Health Forum found no significant reduction in overdoses or mortality associated with B.C.’s safer supply and decriminalization policies. It also suggested possible increases in emergency department visits and hospitalizations.
Comprehensive long-term research on the health impacts of Canadian safer supply programs is limited.
Creating a market
Some sources say the diversion of prescription opioids may be less harmful than the alternatives.
“If you could replace [street] drugs with safer pharmaceutical alternatives, people’s needs would be met,” said Perry Kendall, B.C.’s former provincial health officer and a long-time harm reduction advocate.
“They wouldn’t have to turn to the illicit market, and their risk of a toxic drug overdose would be significantly reduced.”
In Kendall’s view, Schilling was in some ways functioning as a harm-reduction worker.
“[Schilling] was kind of offering a harm reduction service, as well as supplying people with the drugs they wanted,” Kendall said.
Kendall’s views are echoed in a 2023 B.C. government review that notes diversion of safer supply drugs to people already at risk of drug poisoning may be beneficial. But the review also acknowledges that diversion to users who would not otherwise use unregulated drugs is harmful.
Still, Kendall acknowledged a fundamental issue: “[Safer supply opioids don’t] really give you the same high [as fentanyl]. So if you can trade [them] to … get what you’re looking for, which is fentanyl, then that’s what you will do.”
Leonard Krog, the mayor of Nanaimo, says it is clear that, within Nanaimo, B.C.’s policies to help drug users are making it easier for dealers to sell their toxic drugs.
“We have a safe injection site next to City Hall, and there’s no question dealers are coming down here and they’re selling their stuff, because the market’s right here,” said Krog.
But Kendall warns that pulling back on decriminalization and safer supply programs creates a dangerous gap.
“The daftest thing you can do is create a market of desperate people and then fail to fill it,” said Kendall. “Somebody’s going to meet those needs — and they’re not going to be law-abiding citizens.”
Krog is unconvinced.
“If we make it easier for the wolves to successfully exploit the sheep, is that a good thing?”
This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.
Subscribe to Break The Needle
-
Crime1 day ago
Exclusive Analysis: Chinese Couple Smuggled ‘Agroterrorism Weapon’ Fungus into U.S., Echoing Winnipeg Lab Ebola Espionage Case
-
Alberta2 days ago
US media talk to Alberta Premier Danielle Smith in Washington
-
International2 days ago
Musk claims Trump is named in Epstein files after Trump says Elon went ‘CRAZY’
-
Marchant Crane Centrium1 day ago
Marchant Crane Centrium Unveiled at Westerner Park
-
Daily Caller2 days ago
Scott Jennings Dunks Head In Trash Can Upon Mention Of Trump-Musk Feud
-
International2 days ago
Trump, Musk feud explodes on social media
-
COVID-191 day ago
COVID-censured doctor says Liberals targeted him because he made government look bad
-
Health1 day ago
Announcing our $10,000 Second Chance Early Bird Winner!